Related Experiment Video
Updated: Mar 15, 2026

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
EGF receptor ligands: recent advances
Bhuminder Singh1, Graham Carpenter2, Robert J Coffey3
1Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Seven ligands activate the epidermal growth factor receptor (EGFR). High-affinity ligands (EGF, TGFA, HBEGF, BTC) and low-affinity ligands (AREG, EREG, EPGN) have distinct biological actions and interactions with EGFR.
Area of Science:
- Molecular and Cellular Biology
- Receptor Signaling
- Biochemistry
Background:
- The epidermal growth factor receptor (EGFR) is a key regulator of cell growth and differentiation.
- Seven distinct ligands, including EGF, TGFA, HBEGF, BTC, AREG, EREG, and EPGN, are known to bind and activate EGFR.
- Ligands are categorized by affinity: high-affinity (EGF, TGFA, HBEGF, BTC) and low-affinity (AREG, EREG, EPGN).
Purpose of the Study:
- To review recent studies on the individual actions of EGFR ligands.
- To highlight novel biological insights into EGFR ligand activity.
- To discuss recent advances in understanding ligand interactions with EGFR.
Main Methods:
- Literature review of recent scientific studies.
- Analysis of published data on EGFR ligand binding and activation.
- Synthesis of information on ligand-specific biological effects.
Main Results:
- Recent research has elucidated unique biological functions for each of the seven EGFR ligands.
- High-affinity ligands (EGF, TGFA, HBEGF, BTC) exhibit potent signaling, while low-affinity ligands (AREG, EREG, EPGN) mediate distinct cellular responses.
- New understanding has emerged regarding the complex interplay between ligands and the EGFR.
Conclusions:
- The seven EGFR ligands, despite activating the same receptor, possess diverse biological activities.
- Understanding these ligand-specific actions and interactions is crucial for deciphering EGFR-mediated cellular processes.
- Continued research into EGFR ligand biology promises further insights into development and disease.
More Related Videos
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
15:05Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Related Concept Videos
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Tyrosine Kinases